Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1962420141
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5230 E Stop 11 Rd Ste 150
Indianapolis, IN, 46237
Phone (317) 865-5904
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
3,023 services
Medicare patients, 2024
495
Average age 71
Drug cost, 2024
$3.5M
7,285 prescriptions
Company payments, 2023
$19.35
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael J Waddell was code J0897 (injection, denosumab, 1 mg), 1,500 times for 17 patients. In total Michael J Waddell billed 3,023 services in 14 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,500 | 17 | $19.80 | $30K |
| 99214 Office E&M - Established | Office | 508 | 310 | $81.03 | $41K |
| 83036 Blood Count | Office | 238 | 208 | $9.45 | $2,249 |
| 99232 Hospital E&M - Subsequent | Facility | 227 | 85 | $56.14 | $13K |
| 99214 Office E&M - Established | Facility | 114 | 99 | $69.79 | $7,956 |
| 95251 Test - Miscellaneous | Office | 110 | 98 | $24.12 | $2,653 |
| 99231 Hospital E&M - Subsequent | Facility | 108 | 51 | $35.01 | $3,781 |
| 99222 Hospital E&M - Initial | Facility | 59 | 59 | $86.47 | $5,102 |
| 99213 Office E&M - Established | Office | 39 | 37 | $46.95 | $1,831 |
| 95251 Test - Miscellaneous | Facility | 28 | 27 | $25.05 | $701 |
| 96372 Injection Administration | Office | 25 | 17 | $10.50 | $262 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 17 | $12.23 | $208 |
| 99204 Office E&M - New | Office | 12 | 12 | $121.15 | $1,454 |
| 99213 Office E&M - Established | Facility | 11 | 11 | $48.67 | $535 |
By year: 2022 $110K for 3,253 services; 2023 $105K for 2,861 services; 2024 $112K for 3,023 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 238 | 208 | $9.45 | $2,249 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael J Waddell prescribed most often to Medicare patients was Levothyroxine Sodium, with 694 prescriptions and refills. In total Michael J Waddell wrote 7,285 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 694 | 1,867 | 211 | $7,814 |
| Mounjaro Tirzepatide | 312 | 496 | 99 | $534K |
| Atorvastatin Calcium Generic | 310 | 901 | 129 | $2,707 |
| Ozempic Semaglutide | 304 | 632 | 121 | $622K |
| Rosuvastatin Calcium Generic | 300 | 892 | 114 | $3,967 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 295 | 806 | 136 | $67K |
| Metformin Hcl Er Metformin Hcl | 294 | 870 | 128 | $2,877 |
| Jardiance Empagliflozin | 271 | 681 | 102 | $401K |
| Glimepiride Generic | 265 | 746 | 111 | $1,933 |
| Metformin Hcl Generic | 246 | 667 | 83 | $1,623 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 211 | 542 | 110 | $30K |
| Synthroid Levothyroxine Sodium | 162 | 408 | 44 | $14K |
| Lisinopril Generic | 161 | 453 | 59 | $663 |
| Humalog Kwikpen U-100 Insulin Lispro | 153 | 405 | 76 | $107K |
| Ezetimibe Generic | 144 | 433 | 57 | $3,601 |
Brand drugs: 3,329 claims; generic drugs: 3,308 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Michael J Waddell $19.35 ($19.35 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbott Laboratories with $19.35.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $19.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.